Skip to main content
. 2016 May 19;10:863–870. doi: 10.2147/PPA.S79451

Table 4.

Associations between patients’ knowledge about medication treatment and prevalence of medication adherence in outpatients with RA and/or SLE, Goiânia, GO, Brazil, 2013

n=92 (%) RA + SLE (n=92)
RA (n=55)
SLE (n=37)
Prevalence, n (%) P-value Prevalence, n (%) P-value Prevalence, n (%) P-value
Patient is aware of the reason of treatment 1.000a 0.677a 1.000a
 Yes 84 (91.30) 24 (28.57) 8 (16.33) 16 (45.71)
 No 8 (8.69) 2 (25.00) 1 (25.00) 1 (50.00)
Patient is aware of adverse effects 0.728 1.000a 0.769
 Yes 54 (58.69) 16 (29.63) 5 (16.13) 11 (47.83)
 No 38 (41.30) 10 (26.32) 4 (16.66) 6 (42.86)
Patient is aware of drug interactions 0.269 0.680a 0.492
 Yes 18 (20.45) 7 (38.89) 2 (22.22) 5 (55.56)
 No 70 (79.55) 18 (25.71) 7 (15.90) 11 (42.31)
Patient search for more information about medications 0.426 0.467a 0.942
 Yes 46 (50.00) 11 (24.44) 4 (12.50) 7 (46.67)
 No 46 (50.00) 15 (31.91) 5 (21.74) 10 (45.45)

Note:

a

Fisher’s exact test.

Abbreviations: RA, rheumatoid arthritis; SLE, systemic lupus erythematosus.